Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: Efficacy and safety results from a randomized open-label study

1. Roux, C.
2. Hofbauer, L.C.
3. Ho, P.R.
4. Wark, J.D.
5. Zillikens, M.C.
6. Fahrleitner-Pammer, A.
7. Hawkins, F.
8. Micaelo, M.
9. Minisola, S.
10. Papaioannou, N.
11. Stone, M.
12. Ferreira, I.
13. Siddhanti, S.
14. Wagman, R.B.
15. Brown, J.P.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.BONE.2013.10.006 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus